Weinberg J B, Misukonis M A, Goodwin B J
Cancer Res. 1984 Mar;44(3):976-80.
Phorbol diester (PDE) tumor promoters have differing effects on normal and neoplastic hematopoietic cells in vitro. The effects of PDEs on cells are apparently mediated by specific cellular receptors for these ligands. The purpose of this study was to determine if the different phenotypic responses of cells of different human leukemia cell lines were due to differences in the PDE receptors in these cells. All cells of the different lines studied [HL-60 (promyelocytic), HL-60Bll (undifferentiated blastic), U-937 (monoblastic), H-SB2 (T-lymphoblastoid), and SB (B-lymphoblastoid) bound the [20-3H]phorbol-12,13-dibutyrate in a specific manner. The ligand bound to the cells rapidly, reaching a maximum by 10 to 20 min at 37 degrees or by 60 min at 4 degrees. The bound [20-3H]phorbol-12,13-dibutyrate could be fully dissociated from the cells by adding unlabeled phorbol-12,13-dibutyrate; the kinetics of this dissociation paralleled association kinetics. Scatchard analysis of the binding data, derived from experiments done at 4 degrees, revealed linear plots, indicating, most likely, that only single classes of receptors existed on all of these lines. The dissociation constants for binding were all comparable (46 to 152 nM), and the calculated numbers of binding sites were comparable (4.8 to 8.1 X 10(5)/cell). None of the cells could degrade [20-3H]phorbol-12-myristate-13-acetate or [20-3H]phorbol-12,13-dibutyrate as determined by thin-layer chromatographic analysis of cells or supernatants of the cell cultures. PDEs inhibited the proliferation of U-937 and HL-60 cells but not that of the HL-60Bll, SB, or H-SB2 cells. The incorporation of tritiated thymidine into HL-60 cells (but not HL-60Bll cells) was dramatically inhibited by various PDEs, and the potency in causing this inhibition paralleled that known for the potency of the phorbol analogues to cause tumor promotion in vivo or to elicit other in vitro responses from hematopoietic cells. [20-3H]Phorbol-12-myristate-13-acetate caused the HL-60 and U-937 cells to adhere to the plastic, spread, and develop vacuoles, but the other cells displayed no changes. These results suggest that the differing phenotypic responses to PDEs are most likely related to postreceptor factors.
佛波酯(PDE)肿瘤启动子在体外对正常和肿瘤造血细胞有不同影响。PDE 对细胞的作用显然是由这些配体的特定细胞受体介导的。本研究的目的是确定不同人类白血病细胞系细胞的不同表型反应是否归因于这些细胞中 PDE 受体的差异。所研究的不同细胞系 [HL - 60(早幼粒细胞)、HL - 60Bll(未分化母细胞)、U - 937(单核母细胞)、H - SB2(T 淋巴母细胞)和 SB(B 淋巴母细胞)] 的所有细胞都以特异性方式结合 [20 - 3H]佛波醇 - 12,13 - 二丁酸酯。配体迅速与细胞结合,在 37℃下 10 至 20 分钟或在 4℃下 60 分钟达到最大值。通过添加未标记的佛波醇 - 12,13 - 二丁酸酯,结合的 [20 - 3H]佛波醇 - 12,13 - 二丁酸酯可从细胞中完全解离;这种解离动力学与结合动力学平行。对在 4℃下进行的实验所获得的结合数据进行 Scatchard 分析,显示为线性图,这很可能表明所有这些细胞系上仅存在单一类别的受体。结合的解离常数都相当(46 至 152 nM),计算出的结合位点数也相当(4.8 至 8.1×10⁵/细胞)。通过对细胞或细胞培养上清液进行薄层色谱分析确定,没有一种细胞能够降解 [20 - 3H]佛波醇 - 12 - 肉豆蔻酸酯 - 13 - 乙酸酯或 [20 - 3H]佛波醇 - 12,13 - 二丁酸酯。PDE 抑制 U - 937 和 HL - 60 细胞的增殖,但不抑制 HL - 60Bll、SB 或 H - SB2 细胞的增殖。各种 PDE 显著抑制氚标记胸腺嘧啶掺入 HL - 60 细胞(但不抑制 HL - 60Bll 细胞),导致这种抑制的效力与已知的佛波醇类似物在体内引起肿瘤促进或从造血细胞引发其他体外反应的效力相当。[20 - 3H]佛波醇 - 我12 - 肉豆蔻酸酯 - 13 - 乙酸酯使 HL - 60 和 U - 937 细胞粘附于塑料表面、铺展并形成液泡,但其他细胞未显示变化。这些结果表明,对 PDE 的不同表型反应很可能与受体后因素有关。